Darunavir - CAS# 206361-99-1 Catalog No.:M10170-10 InChi: InChI=1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9

InChi: InChI=1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9

3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid

InChiKey: JHBWYQRKOUBPCA-UHFFFAOYSA-N

GSK0660 antagonizes 100% of the activity of PPARβ/δ with a pIC50 of 6

Darunavir - CAS# 206361-99-1 Catalog No.:M10170-10 InChi: InChI=1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment nave and treatment experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. .